SILVIA
CALABUIG FARIÑAS
PROF. PERMANENT LABORAL PPL
Hospital General Universitario de Valencia
Valencia, EspañaPublications in collaboration with researchers from Hospital General Universitario de Valencia (60)
2024
-
KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination
Cell Communication and Signaling, Vol. 22, Núm. 1
-
Soluble galectin-3 as a microenvironment-relevant immunoregulator with prognostic and predictive value in lung adenocarcinoma
Molecular Oncology, Vol. 18, Núm. 1, pp. 190-215
2023
-
A Sonic Hedgehog Pathway Score to Predict the Outcome of Resected Non-Small Cell Lung Cancer Patients
Annals of Surgical Oncology, Vol. 30, Núm. 2, pp. 1225-1235
-
ASO Visual Abstract: A Sonic Hedgehog Pathway Score to Predict the Outcome of Resected Non-small Cell Lung Cancer Patients
Annals of surgical oncology, Vol. 30, Núm. 2, pp. 1238-1239
-
Circulating Immune Proteins: Improving the Diagnosis and Clinical Outcome in Advanced Non-Small Cell Lung Cancer
International Journal of Molecular Sciences, Vol. 24, Núm. 24
-
Clinical and technical insights of tumour mutational burden in non-small cell lung cancer
Critical Reviews in Oncology/Hematology, Vol. 182
2022
-
Analysis of Exosomal Cargo Provides Accurate Clinical, Histologic and Mutational Information in Non-Small Cell Lung Cancer
Cancers, Vol. 14, Núm. 13
-
Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer
Cancers, Vol. 14, Núm. 2
2021
-
3D printing novel in vitro cancer cell culture model systems for lung cancer stem cell study
Materials Science and Engineering C, Vol. 122
-
Analysis of the gut microbiota: An emerging source of biomarkers for immune checkpoint blockade therapy in non-small cell lung cancer
Cancers, Vol. 13, Núm. 11
-
Cancer epigenetic biomarkers in liquid biopsy for high incidence malignancies
Cancers, Vol. 13, Núm. 12
-
Characterization of circulating t cell receptor repertoire provides information about clinical outcome after pd-1 blockade in advanced non-small cell lung cancer patients
Cancers, Vol. 13, Núm. 12
-
Differentially methylated genes in proliferative verrucous leukoplakia reveal potential malignant biomarkers for oral squamous cell carcinoma
Oral Oncology, Vol. 116
-
Exosomal microRNAs in non-small cell lung cancer
Translational Cancer Research, Vol. 10, Núm. 6, pp. 3128-3139
-
NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment
Molecular Oncology, Vol. 15, Núm. 9, pp. 2363-2376
-
R-score: A new parameter to assess the quality of variants’ calls assessed by ngs using liquid biopsies
Biology, Vol. 10, Núm. 10
-
The status of egfr modulates the effect of mirna-200c on zeb1 expression and cell migration in glioblastoma cells
International Journal of Molecular Sciences, Vol. 22, Núm. 1, pp. 1-18
-
Update on systemic treatment in early triple negative breast cancer
Therapeutic Advances in Medical Oncology, Vol. 13
-
dPCR application in liquid biopsies: divide and conquer
Expert Review of Molecular Diagnostics, Vol. 21, Núm. 1, pp. 3-15
2020
-
A profile on cobas® EGFR Mutation Test v2 as companion diagnostic for first-line treatment of patients with non-small cell lung cancer
Expert Review of Molecular Diagnostics, Vol. 20, Núm. 6, pp. 575-582